(Q42454519)

31 October 2017

Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. (English)

1 reference

31 October 2017

0 references

Gräfe M

1

1 reference

31 October 2017

Auch-Schwelk W

2

1 reference

31 October 2017

Hertel H

3

1 reference

31 October 2017

Terbeek D

4

1 reference

31 October 2017

Steinheider G

5

1 reference

31 October 2017

Loebe M

6

1 reference

31 October 2017

Fleck E

7

1 reference

31 October 2017

1 March 1998

1 reference

31 October 2017

1 reference

31 October 2017

137

1 reference

31 October 2017

87-95

1 reference

31 October 2017

1

1 reference

Role of thrombosis in atherosclerosis and its complications

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Transcriptional regulation of tissue factor expression in human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

A Sensitive Fluorimetric Assay for Serum Angiotensin-con venrting Enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

A fluorometric assay for angiotensin-converting enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Regulation of the Tissue Factor Promoter in Endothelial Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Different phenotypes of cultured microvessel endothelial cells obtained from bovine corpus luteum. Study by light microscopy and by scanning electron microscopy (SEM)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Effect of low density lipoprotein on monocyte adhesiveness to endothelial cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Lysophosphatidylcholine inhibits surface receptor-mediated intracellular signals in endothelial cells by a pathway involving protein kinase C activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Suppression of endothelin-1 secretion by lysophosphatidylcholine in oxidized low density lipoprotein in cultured vascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atheroscleros

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

Silver staining of proteins in polyacrylamide gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900258-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(97)00258-X

1 reference

31 October 2017

1 reference